Europe Impulse Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034

Coverage: By Product (Device and Accessories), Device for Product (Desktop and Portable), Accessories for Product (Filters, Nose Clip, Support Arms, and Other Accessories), Application (Asthma, COPD, and Other Applications), and End User (Hospitals and Clinics, Diagnostic Laboratories, and Other End users)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Published
  • Report Code : TIPRE00043933
  • Category : Life Sciences
  • No. of Pages : 160
  • Available Report Formats : pdf-format excel-format
  • Last update date : July 31, 2026
Europe Impulse Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034
Report Date: July 31, 2026   |   Report Code: TIPRE00043933 Email: sales@theinsightpartners.com

2025 Market Size

US$

Base year value

2034 Forecast

US$

Projected by 2034

CAGR 2026-2034

6.0 %

Growth rate

Addressable Market

US$ 285,774.85 THOUSAND

(2026-2034)

The Europe Impulse Oscillometry Market size is expected to reach US$ 39,359.3 Thousand by 2034 from US$ 23,461.1 Thousand in 2025. The market is estimated to record a CAGR of 6.0% from 2026 to 2034.

Executive Summary and Europe Impulse Oscillometry Market Analysis:

The Europe impulse oscillometry market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The rising prevalence of chronic respiratory diseases such as Asthma and chronic obstructive pulmonary disease (COPD) increases demand for advanced lung function diagnostics beyond traditional spirometry. IOS offers effort-independent testing that can detect small-airway dysfunction and provide detailed airway resistance and reactance data during normal breathing, making it useful for pediatric, elderly, or frail patients who struggle with conventional tests. Modern IOS devices are portable, user-friendly, and compatible with integrated digital health systems, enhancing adoption across hospitals, specialist clinics, and home care settings. Healthcare systems focus on preventive care, early disease detection, and telehealth integration, which bolsters demand for sophisticated diagnostics such as IOS. The aging population in Europe contributes to a higher incidence of respiratory disorders, prompting increased utilization of lung function testing technologies. Surging clinical acceptance of IOS-driven by its sensitivity to early airway changes and complementary role alongside spirometry-is encouraging healthcare providers to incorporate these systems into routine respiratory assessment protocols.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Europe Impulse Oscillometry Market: Strategic Insights

europe-impulse-oscillometry-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Impulse Oscillometry Market Segmentation Analysis:

  • By Product, the Europe Impulse Oscillometry Market is segmented into Device and Accessories. The Device segment dominated the market in 2025.
  • By Device For Product, the Europe Impulse Oscillometry Market is segmented into Desktop and Portable. The Desktop segment dominated the market in 2025.
  • By Accessories For Product, the Europe Impulse Oscillometry Market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment dominated the market in 2025.
  • By Application, the Europe Impulse Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment dominated the market in 2025.
  • By End User, the Europe Impulse Oscillometry Market is segmented into Hospitals and Clinics, Diagnostic Laboratories, and Other End users. The Hospitals and Clinics segment dominated the market in 2025.

Europe Impulse Oscillometry Market Report Scope

Report Attribute Details
Market size in 2025 US$ 23,461.1 Thousand
Market Size by 2034 US$ 39,359.3 Thousand
CAGR (2026 - 2034) 6.0%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Device
  • Accessories
By Device For Product
  • Desktop
  • Portable
By Accessories For Product
  • Filters
  • Nose Clip
  • Support Arms
  • Other Accessories
By Application
  • Asthma
  • COPD
  • Other Applications
Regions and Countries Covered Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
Market leaders and key company profiles
  • COSMED Srl
  • Chest MI Inc
  • Morgan Scientific Inc
  • THORASYS Thoracic Medical Systems Inc.
  • Jaeger Medical GmbH
  • GANSHORN Medizin Electronic GmbH
  • Vitalograph Ltd
  • Lothar Medical GmbH
  • Cognita Labs, LLC
  • RESTECH srl

Europe Impulse Oscillometry Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Impulse Oscillometry Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

europe-impulse-oscillometry-market-cagr

Europe Impulse Oscillometry Market Outlook

IOS systems, such as those incorporating forced oscillation techniques with advanced signal processing, allow for real-time data analysis, as demonstrated by the Tremoflo C-100 from Thorasys, which uses airway oscillometry to measure lung impedance with minimal patient effort. Integration of digital interfaces and Bluetooth connectivity enables seamless data transfer to electronic health records, improving clinical workflows. The European Respiratory Society (ERS) guidelines emphasize IOS's evolution with software algorithms that are correct for artifacts, boosting diagnostic reliability. Portable handheld IOS devices, including the Resmon Pro from Restech, have miniaturized components using microelectromechanical systems (MEMS) technology, allowing assessments in home or remote settings, which is crucial for monitoring chronic conditions. According to the FDA, multiple 510(k) clearances in 2023-2024 for oscillometric home BP monitors with Bluetooth connectivity improved adherence tracking. Advancements in sensor technology, such as piezoelectric transducers, provide higher frequency ranges up to 100 Hz, enabling detailed small airway evaluations, as noted in studies from the Journal of Applied Physiology. Battery-powered and wireless designs address mobility needs, particularly in pediatric or elderly care, where traditional spirometry fails.

Hybrid systems combining IOS with capnography or plethysmography offer comprehensive pulmonary function testing. These innovations lower costs through efficient manufacturing and expand applications to telemedicine, where remote IOS monitoring has been validated in trials by the National Institutes of Health (NIH), showing comparable results to in-clinic tests. Enhanced calibration techniques using standardized phantoms ensure reproducibility and align with ISO standards for medical devices. These technological strides are making IOS an indispensable tool in modern respiratory diagnostics, adapting to evolving healthcare demands.

Europe Impulse Oscillometry Market Country Insights

By country, the Europe Impulse Oscillometry Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2025.

Germany faces a notable burden from respiratory diseases, where Impulse Oscillometry (IOS) plays an important supportive role in assessment. The Robert Koch Institute (RKI) Journal of Health Monitoring (2023) estimates bronchial asthma prevalence at 9%, affecting millions and contributing to emergency visits and reduced quality of life, especially in children and adults with allergic components. According to the RKI, the annual prevalence of COPD is 5.8% in Germany. COPD remains a leading cause of hospital admissions and mortality in older populations. IOS provides an effort-independent, noninvasive alternative to spirometry for evaluating small airway function, which is useful in early detection of obstruction in Asthma and COPD, as well as in monitoring treatment responses in patients who cannot perform forced maneuvers, such as young children or the elderly.

According to Destatis, the population aged 65 and older reached 19 million in 2024, comprising 22.3% of the total, heightening the need for IOS in elderly patients with reduced spirometry compliance. The European Respiratory Society's 2023 recommendations supported IOS integration in German pulmonary clinics for asthma-COPD overlap and interstitial lung disease evaluation.

Europe Impulse Oscillometry Market Company Profiles

Some of the key players operating in the market include COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, GANSHORN Medizin Electronic GmbH, Vitalograph Ltd, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Impulse Oscillometry Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA